Surface plasmon resonance imaging sensor for cathepsin determination based on immobilized cystatin

Protein and Peptide Letters

Volumn 16, Issue 11, 2009, Pages 1379-1385

  Gorodkiewicz, E ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Biosensor; Blood plasma; Cathepsins; Cystatin; Leukocytes; Surface plasmon resonance imaging

Indexed keywords

CATHEPSIN; CYSTATIN; IMMOBILIZED PROTEIN;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; CHICKEN; GENETIC PROCEDURES; HUMAN; LEUKEMIA; METABOLISM; METHODOLOGY; PH; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

ANIMALS; BIOSENSING TECHNIQUES; CATHEPSINS; CHICKENS; CYSTATINS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMOBILIZED PROTEINS; LEUKEMIA; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 70349948839     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609789353754     Document Type: Article

References (27)

1. Turk, V.; Turk, B.; Gunčar, G.; Turk, D.; Kos, J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Advan. Enzyme Regul., 2002, 42, 285-303. (Pubitemid 35033544)
2. Travis, J.; Potempa, J.; Maeda, H. Are bacterial proteinases pathogenic factors? Trends Microbiol., 1995, 3(10), 405-407.
3. http://www.laboratoria.net/pl/modules.php?name=News&file= article&sid= 1947
4. Carvajal-Rondanelli, P. Diffusion of protease inhibitors in the muscle cell, PhD dissertation, Graduate Faculty of North. Carolina State University, Department of Food Science, USA, 2002.
5. Buck, M.R.; Karustis, D.G.; Day, N.A.; Honn, K.V.; Sloane, B.F. Degradation of extracellular-matrix proteins by human cathepsin. B from normal and tumor tissues. Biochem. J., 1992, 282, 273-278.
6. Talieri, M.; Papadopoulou, S.; Scorilasf, A.; Xynopoulosb, D.; Arnogianakic, N.; Plataniotisd, G.; Yotise, J.; Agnantig, N. Cathepsin B and cathepsin. D. Expression in the progression of colorectal adenoma to carcinoma. Cancer Lett., 2004, 205, 97-106. (Pubitemid 38230144)
7. Bien, S.; Ritter, C. A.; Gratz, M.; Sperker, B.; Sonnemann, J.; Beck, J. F.; Kroemer, H. K. Nuclear factor- b mediates up-regulation, of cathepsin b by doxorubicin in tumor cells. Mol. Pharmacol, 2004, 65(5), 1092-1102.
8. Leigh, A. Candidate-based proteomics In the search for biomarkers of cardiovascular disease. J. Physiol., 2005, 563(1), 23-60. (Pubitemid 40340365)
9. Kirschke, H.; Wiederanders, B.; Brömme, D.; Rinne, A. Cathepsin S from bovine spleen. Biochem. J., 1989, 264, 467-473.
10. Fusek, M.; Větviǐka, V. Dual role of cathepsin D: ligand and protease. Biomed. Papers, 2005, 149(1), 43-50.
11. Sivaparvathi, M.; Sawaya, R.; Chintala, S.K.; Go, Y.; Gokaslan, Z.L.; Rao, J.S. Expression of cathepsin D during the progression of human gliomas. Neurosci. Lett., 1996, 208,171-174. (Pubitemid 26140149)
12. Preston, A. Extracellular matrix proteases & protein technical guide; Calbiochem, Oncog. Res. Prod., 2002,VoI. 2, pp. 1-20.
13. Golabek, A.A. Tripeptydylo-peplydaza I - wystçpowanie, biogeneza i mechanizmy aktywacji. Postepy Biochemii (Poland), 2006, 52(1), 16-23.
14. Szajda, S.D.; Jakimiec-Roszkowska, W.; Snarska, J.; Zwierz, K. Aktywnošó katepsyny D w surowicy krwi i moczu chorych na raka jelita grubego. Wspólczesna Onkologia (Poland), 2006, 10(7), 321-323.
15. Bangalore, N.; Travis, J.; Onunka, V.C.; Pohl, J.; Shafer, W.M. Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J. Biol. Chem., 1990, 265(23), 13584-13588 (Pubitemid 20252209)
16. Chu, Q.; Jones, S.; Zeece, M. Capillary electrophoretic determination of cathepsin D actvity using Oregon Green-labeled hemoglobin. Electrophoresis, 1999, 20(14), 2945-2951 (Pubitemid 29517226)
17. http://en.wikipedia.org/wiki/Cathepsin-G
18. Baechle, D.; Cansier, A.; Fischer, R.; Brandenburg, J.; Burster, T.; Driessen, C.; Kalbacher, H. Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity. J. Pept. Sci., 2004, 11(3), 166-174. (Pubitemid 40347549)
19. Razumović, U.J.; Stojković, R.R.; Petrovećki, M.;Gamulin S. Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol). Breast Cancer Res. Treat., 1991, 43(2), 117-122(6).
20. Fu, S.; Chu, S. G.; Qin, Z. F.; Xu, X. B. Determination of cathepsin D activity in mcf-7 cells by capillary zone electrophoresis with, on -column sample stacking. Chromatographia, 2003, 58 (1-2), 7378.
21. Steiner, G. Surface plasmon resonance imaging. Anal. Bioanal. Chem., 2004, 379, 328-331.
22. Homola, J., Yee, S.S.; Gauglitz, G. Surface plasmon resonance sensors: review. Sens. Actual B: Chem., 1999, 54, 3-15.
23. Gorodkiewicz, E. The surface plasmone resonance imaging sensor for papain based on immobilized cystatin. Protein Pept. Lett., 2007, 14, 443-445. (Pubitemid 46833870)
24. Gorodkiewicz, E.; Fernández-González, A.; Akkoyun, A.; Steiner, G.; Salzer, R. Systematic evaluation of a spr imaging biochip reader: study of gold surface modifications. Chem. Anal. (Warsaw), 2005, 50, 103-115. (Pubitemid 44383577)
25. Illy, C.; Quraishi, O.; Wang, J.; Purisima, E.; Vernet T.; Mort, J.S. mort role of the occluding loop in cathepisn B activity. J Biol. Chem, 1997, 272(2), 1197-1202.
26. Björk, I,; Pol, E.; Raub-Segall, E.; Abrahamson, M.; Rowan, A.D.; Mort, J.S. Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem J., 1994, 299(Pt 1), 219-225. (Pubitemid 24106313)
27. Kos, J.; Nielsen, H.J.; Krasovec, M.; Christensen, I.J.; Cimerman, N.; Stephens R.W.; Brunner, N. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin. Cancer Res., 1998, 4(6), 1511-1516. (Pubitemid 28265236)